Efficacy and Safety of Different Dosages of Mexidol in Patients With Primary Open-angle Glaucoma (POAG)
Status:
COMPLETED
Trial end date:
2023-09-07
Target enrollment:
Participant gender:
Summary
The present trial is planned to investigate and identify the best dosage of investigational drugs with respect to the treatment of open-angle glaucoma. Therefore, multiple dose regimens of the investigational drug versus placebo drug are anticipated.